Date published: 2025-10-30

1-800-457-3801

SCBT Portrait Logo
Seach Input

KLKb8 Inhibitors

Chemical inhibitors of KLKb8 function through various mechanisms to impede its proteolytic activity. AEBSF operates by covalently modifying the serine residue in the active site of KLKb8, nullifying its enzymatic function. Similarly, Gabexate and Camostat engage directly with KLKb8, binding to its active site. Gabexate achieves this through a temporary bond, while Camostat forms a more enduring covalent attachment to the serine residue, both resulting in the inhibition of substrate cleavage. Nafamostat also forms a transient covalent bond with the active serine residue of KLKb8, leading to the direct inhibition of its protease activity. Aprotinin, another inhibitor, takes a different approach by forming a stable complex with KLKb8, which blocks the substrate-binding site, preventing enzyme-substrate interaction. Leupeptin further extends the diversity of inhibition by reversibly binding to KLKb8, masking the active site and thus prohibiting substrate cleavage. Other inhibitors affect KLKb8 activity indirectly, by targeting proteases that either activate KLKb8 or degrade its natural inhibitors. E-64, for example, inhibits cysteine proteases that could be involved in either stabilizing KLKb8 activity or cleaving its inhibitors. Pepstatin A, on the other hand, inhibits aspartyl proteases that may play a role in KLKb8 activation through proteolytic processing. Chymostatin prevents activation of KLKb8 by inhibiting chymotrypsin-like proteases, while Phosphoramidon inhibits metalloproteases that could be involved in the activation of KLKb8 or in the degradation of its inhibitors. Bestatin impedes aminopeptidases that may be necessary for the maturation or activation of KLKb8, or that may inactivate peptide inhibitors of KLKb8. Additionally, Marimastat, as a broad-spectrum metalloprotease inhibitor, can indirectly suppress KLKb8 by inhibiting metalloproteases that are potentially involved in its activation cascade or by preserving the integrity of its natural inhibitors. Through these diverse mechanisms, each chemical plays a role in modulating the activity of KLKb8.

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

AEBSF hydrochloride

30827-99-7sc-202041
sc-202041A
sc-202041B
sc-202041C
sc-202041D
sc-202041E
50 mg
100 mg
5 g
10 g
25 g
100 g
$50.00
$120.00
$420.00
$834.00
$1836.00
$4896.00
33
(1)

AEBSF is a serine protease inhibitor that can directly inhibit KLKb8 by covalently modifying the serine residue in the active site of the enzyme, which is essential for its proteolytic activity.

Aprotinin

9087-70-1sc-3595
sc-3595A
sc-3595B
10 mg
100 mg
1 g
$110.00
$400.00
$1615.00
51
(2)

Aprotinin is a small protein protease inhibitor that inhibits several serine proteases including KLKb8 by forming a stable complex with the protease, thereby blocking access to the substrate-binding site.

Leupeptin hemisulfate

103476-89-7sc-295358
sc-295358A
sc-295358D
sc-295358E
sc-295358B
sc-295358C
5 mg
25 mg
50 mg
100 mg
500 mg
10 mg
$72.00
$145.00
$265.00
$489.00
$1399.00
$99.00
19
(3)

Leupeptin is a reversible inhibitor of serine and cysteine proteases that binds to and inhibits KLKb8 by masking the active site of the enzyme, preventing substrate cleavage.

E-64

66701-25-5sc-201276
sc-201276A
sc-201276B
5 mg
25 mg
250 mg
$275.00
$928.00
$1543.00
14
(0)

E-64 is a cysteine protease inhibitor that can indirectly inhibit KLKb8 by inhibiting downstream proteases which, when active, may stabilize or enhance KLKb8 activity through proteolytic cascades or by cleaving inhibitors of KLKb8.

Chymostatin

9076-44-2sc-202541
sc-202541A
sc-202541B
sc-202541C
sc-202541D
5 mg
10 mg
25 mg
50 mg
100 mg
$153.00
$255.00
$627.00
$1163.00
$2225.00
3
(1)

Chymostatin is an inhibitor of chymotrypsin-like proteases and, by extension, can indirectly inhibit KLKb8 activity by preventing proteolytic events that could lead to the activation or stabilization of KLKb8.

Phosphoramidon

119942-99-3sc-201283
sc-201283A
5 mg
25 mg
$195.00
$620.00
8
(1)

Phosphoramidon is a metalloprotease inhibitor that could indirectly inhibit KLKb8 by inhibiting metalloproteases involved in the proteolytic activation of KLKb8 or by degrading inhibitors of KLKb8, thus promoting its inhibition.

Bestatin

58970-76-6sc-202975
10 mg
$128.00
19
(3)

Bestatin is an aminopeptidase inhibitor that can indirectly inhibit KLKb8 activity by inhibiting aminopeptidases that may be required for the maturation or activation of KLKb8 or by cleaving and inactivating peptide inhibitors of KLKb8.

Gabexate mesylate

56974-61-9sc-215066
5 mg
$100.00
(0)

Gabexate is a broad-spectrum serine protease inhibitor that directly inhibits KLKb8 by binding to its active site, thereby blocking its enzymatic activity.

Camostat mesylate

59721-29-8sc-203867
sc-203867A
sc-203867B
sc-203867C
sc-203867D
sc-203867E
10 mg
50 mg
500 mg
1 g
10 g
100 g
$42.00
$179.00
$306.00
$612.00
$2040.00
$4386.00
5
(0)

Camostat is a serine protease inhibitor that directly inhibits KLKb8 by covalently binding to the serine residue at the active site, preventing substrate access and cleavage.

Nafamostat mesylate

82956-11-4sc-201307
sc-201307A
10 mg
50 mg
$80.00
$300.00
4
(1)

Nafamostat is a synthetic serine protease inhibitor that inhibits KLKb8 directly by forming a transient covalent bond with the active serine residue, thereby inhibiting its protease activity.